Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis is a rapidly progressive neurodegenerative disease that affects 1/350 individuals in the United Kingdom. The cause of amyotrophic lateral sclerosis is unknown in the majority of cases. Two-sample Mendelian randomization enables causal inference between an exposure, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Boddy, Sarah, Islam, Mahjabin, Moll, Tobias, Kurz, Julian, Burrows, David, McGown, Alexander, Bhargava, Anushka, Julian, Thomas H, Harvey, Calum, Marshall, Jack NG, Hall, Benjamin PC, Allen, Scott P, Kenna, Kevin P, Sanderson, Eleanor, Zhang, Sai, Ramesh, Tennore, Snyder, Michael P, Shaw, Pamela J, McDermott, Christopher, Cooper-Knock, Johnathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010771/
https://www.ncbi.nlm.nih.gov/pubmed/35441136
http://dx.doi.org/10.1093/braincomms/fcac069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010771/
https://www.ncbi.nlm.nih.gov/pubmed/35441136
http://dx.doi.org/10.1093/braincomms/fcac069

Ejemplares similares